338 related articles for article (PubMed ID: 21627632)
1. NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies.
Wallace JL
Br J Pharmacol; 2012 Jan; 165(1):67-74. PubMed ID: 21627632
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.
Wallace JL
World J Gastroenterol; 2013 Mar; 19(12):1861-76. PubMed ID: 23569332
[TBL] [Abstract][Full Text] [Related]
3. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?
Adebayo D; Bjarnason I
Postgrad Med J; 2006 Mar; 82(965):186-91. PubMed ID: 16517800
[TBL] [Abstract][Full Text] [Related]
4. NSAID enteropathy and bacteria: a complicated relationship.
Syer SD; Blackler RW; Martin R; de Palma G; Rossi L; Verdu E; Bercik P; Surette MG; Aucouturier A; Langella P; Wallace JL
J Gastroenterol; 2015 Apr; 50(4):387-93. PubMed ID: 25572030
[TBL] [Abstract][Full Text] [Related]
5. NSAID-gastroenteropathy: new aspects of pathogenesis and prevention.
Blackler RW; Gemici B; Manko A; Wallace JL
Curr Opin Pharmacol; 2014 Dec; 19():11-6. PubMed ID: 24929967
[TBL] [Abstract][Full Text] [Related]
6. [Small bowel injuries due to nonsteroidal anti-inflammatory drugs and antiplatelet therapy. Approaches to prevention and treatment].
Drapkina OM; Korneeva ON
Ter Arkh; 2016; 88(12):133-139. PubMed ID: 28635889
[TBL] [Abstract][Full Text] [Related]
7. FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats.
Said H; Akiba Y; Narimatsu K; Maruta K; Kuri A; Iwamoto KI; Kuwahara A; Kaunitz JD
Dig Dis Sci; 2017 Aug; 62(8):1944-1952. PubMed ID: 28523577
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drug gastropathy and cytoprotection: pathogenesis and mechanisms re-examined.
Wallace JL
Scand J Gastroenterol Suppl; 1992; 192():3-8. PubMed ID: 1439567
[TBL] [Abstract][Full Text] [Related]
9. Detection and prevention of NSAID-induced enteropathy.
Davies NM; Saleh JY; Skjodt NM
J Pharm Pharm Sci; 2000; 3(1):137-55. PubMed ID: 10954683
[TBL] [Abstract][Full Text] [Related]
10. NSAID-induced small intestinal damage--roles of various pathogenic factors.
Takeuchi K; Satoh H
Digestion; 2015; 91(3):218-32. PubMed ID: 25791157
[TBL] [Abstract][Full Text] [Related]
11. NSAID enteropathy: could probiotics prevent it?
Montalto M; Gallo A; Gasbarrini A; Landolfi R
J Gastroenterol; 2013 Jun; 48(6):689-97. PubMed ID: 22875474
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal antiinflammatory drugs and the small intestine.
Fortun PJ; Hawkey CJ
Curr Opin Gastroenterol; 2005 Mar; 21(2):169-75. PubMed ID: 15711208
[TBL] [Abstract][Full Text] [Related]
13. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
Fialová P; Vlcek J
Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
[TBL] [Abstract][Full Text] [Related]
14. [NSAID enteropathy].
Kareva EN
Ter Arkh; 2020 Apr; 92(2):85-92. PubMed ID: 32598724
[TBL] [Abstract][Full Text] [Related]
15. [Adherence with proton pump inhibitor therapy, by continuously taking nonsteroidal anti-inflammatory drugs].
Pimanov SI; Makarenko EV; Dikareva EA
Ter Arkh; 2015; 87(4):58-61. PubMed ID: 26087636
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
Steen KS; Lems WF; Dijkmans BA
Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1649-52. PubMed ID: 10494299
[TBL] [Abstract][Full Text] [Related]
17. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.
Bjarnason I; Takeuchi K
J Gastroenterol; 2009; 44 Suppl 19():23-9. PubMed ID: 19148789
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatories and gastroduodenal damage: therapeutic options.
Agrawal NM
Eur J Rheumatol Inflamm; 1993; 13(1):17-24. PubMed ID: 7821335
[TBL] [Abstract][Full Text] [Related]
19. Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.
Zhong ZY; Sun BB; Shu N; Xie QS; Tang XG; Ling ZL; Wang F; Zhao KJ; Xu P; Zhang M; Li Y; Chen Y; Liu L; Xia LZ; Liu XD
Acta Pharmacol Sin; 2016 Jul; 37(7):1002-12. PubMed ID: 27180979
[TBL] [Abstract][Full Text] [Related]
20. Processed Aloe vera gel attenuates non-steroidal anti-inflammatory drug (NSAID)-induced small intestinal injury by enhancing mucin expression.
Kim MW; Kang JH; Shin E; Shim KS; Kim MJ; Lee CK; Yoon YS; Oh SH
Food Funct; 2019 Sep; 10(9):6088-6097. PubMed ID: 31490512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
